What's new — ADHD¶
Generated 2026-11-01 from the publication dates of every paper cited in this condition's pages.
This page answers a different question from the curation log. The log says when we last edited a page; this says how recent the evidence on those pages is — so you can tell settled ground from a field that is actively moving, and jump straight to what has emerged lately.
How much of this condition's evidence is recent¶
| Published within | Cited papers |
|---|---|
| last week | 0 |
| last month | 4 |
| last 2 months | 17 |
| last 3 months | 26 |
| last 6 months | 36 |
| last year | 66 |
| older than a year | 415 |
Counts are cumulative: a paper from last week also counts inside "last month". Dates are PubMed publication or e-publication dates, so a paper may have appeared online before its journal issue.
Newest evidence first¶
The most recent cited papers, with the pages that use them.
| Published | Paper | Cited on |
|---|---|---|
| 2026-10-09 | Effect of Digital Technology-Based Interventions on Core Symptoms and Cognitive Function in Children With Attention-Deficit/Hyperactivity Disorder: Systematic Review and Meta-Analysis — J Med Internet Res ([PMID 42854193](https://pubmed.ncbi.nlm.nih.gov/42854193/){target="_blank" rel="noopener"}) | psychosocial-and-digital-treatment |
| 2026-10-08 | Sustained increases in ADHD medication use after the COVID-19 pandemic: A nationwide register-based study — Scand J Public Health ([PMID 42847285](https://pubmed.ncbi.nlm.nih.gov/42847285/){target="_blank" rel="noopener"}) | epidemiology-and-lifespan-course |
| 2026-10-07 | Attention-Deficit/Hyperactivity Disorder and Late-Life Cognitive Impairment — JAMA Psychiatry ([PMID 42842281](https://pubmed.ncbi.nlm.nih.gov/42842281/){target="_blank" rel="noopener"}) | adult-adhd, long-term-outcomes-and-quality-of-life |
| 2026-10-04 | A Phase 3, Multicenter, Randomized, Placebo-Controlled Trial Evaluating the Efficacy, Safety, and Tolerability of Serdexmethylphenidate/d-Methylphenidate Capsules in Chinese Children with Attention-Deficit/Hyperactivity Disorder — CNS Drugs ([PMID 42830387](https://pubmed.ncbi.nlm.nih.gov/42830387/){target="_blank" rel="noopener"}) | clinical-trials-landscape |
| 2026-10-01 | Adverse sexual and reproductive health outcomes in female adolescents with ADHD and their associations with ADHD medication: a Swedish register-based study — BMJ Ment Health ([PMID 42864120](https://pubmed.ncbi.nlm.nih.gov/42864120/){target="_blank" rel="noopener"}) | girls-women-and-hormonal-context |
| 2026-10-01 | Trends in Parent-Reported Developmental Disabilities: 2019-2024 — Pediatrics ([PMID 42767652](https://pubmed.ncbi.nlm.nih.gov/42767652/){target="_blank" rel="noopener"}) | epidemiology-and-lifespan-course |
| 2026-09-09 | Therapist-guided Internet-delivered versus Face-to-face CBT for Adults with ADHD: Differential Long-Term Maintenance and Exploratory Correlational Pathways — J Atten Disord ([PMID 42717581](https://pubmed.ncbi.nlm.nih.gov/42717581/){target="_blank" rel="noopener"}) | adult-adhd, psychosocial-and-digital-treatment |
| 2026-09-09 | Changes in Characteristics Associated With ADHD and ASD Diagnoses Over Time — JAMA Psychiatry ([PMID 42714883](https://pubmed.ncbi.nlm.nih.gov/42714883/){target="_blank" rel="noopener"}) | epidemiology-and-lifespan-course |
| 2026-09-02 | Major adverse cardiac events and mortality associated with ADHD and its treatment in adults with type 2 diabetes: a multi-national cohort study — BMC Med ([PMID 42806384](https://pubmed.ncbi.nlm.nih.gov/42806384/){target="_blank" rel="noopener"}) | pharmacologic-treatment |
| 2026-09-02 | National Trends in Severe ADHD and Treatment Among U.S. Children, 2016-2024 — Acad Pediatr ([PMID 42805290](https://pubmed.ncbi.nlm.nih.gov/42805290/){target="_blank" rel="noopener"}) | epidemiology-and-lifespan-course |
| 2026-09-02 | Effect of pharmacological treatment of attention-deficit hyperactivity disorder on academic performance: registry-based population study — Br J Psychiatry ([PMID 42803341](https://pubmed.ncbi.nlm.nih.gov/42803341/){target="_blank" rel="noopener"}) | long-term-outcomes-and-quality-of-life |
| 2026-09-02 | Clinically Meaningful Within-Patient Change in Core Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents Treated With Centanafadine: Results From Two Phase 3 Randomized Clinical Trials — J Atten Disord ([PMID 42779129](https://pubmed.ncbi.nlm.nih.gov/42779129/){target="_blank" rel="noopener"}) | clinical-trials-landscape, pharmacologic-treatment |
| 2026-09-02 | Prenatal exposure to paracetamol and the risk of autism and attention-deficit/hyperactivity disorder: An umbrella review and meta-meta-analysis — Dev Med Child Neurol ([PMID 42773841](https://pubmed.ncbi.nlm.nih.gov/42773841/){target="_blank" rel="noopener"}) | girls-women-and-hormonal-context |
| 2026-09-01 | Efficacy and safety of noninvasive brain stimulation for ADHD: a systematic review and meta-analysis of double-blind randomized controlled trials across international English and Chinese databases — Psychiatry Res ([PMID 42772174](https://pubmed.ncbi.nlm.nih.gov/42772174/){target="_blank" rel="noopener"}) | psychosocial-and-digital-treatment |
| 2026-09-01 | Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults — Int J Risk Saf Med ([PMID 42751977](https://pubmed.ncbi.nlm.nih.gov/42751977/){target="_blank" rel="noopener"}) | pharmacologic-treatment |
| 2026-09-01 | Age at Diagnosis and Clinical and Genetic Profiles Among Adults With Attention-Deficit/Hyperactivity Disorder — JAMA Netw Open ([PMID 42747853](https://pubmed.ncbi.nlm.nih.gov/42747853/){target="_blank" rel="noopener"}) | adult-adhd |
| 2026-09-01 | ADHD medication use and risk of self-harm: a multinational self-controlled case series study — BMJ Ment Health ([PMID 42731881](https://pubmed.ncbi.nlm.nih.gov/42731881/){target="_blank" rel="noopener"}) | pharmacologic-treatment, red-flags-and-safety-concerns |
| 2026-08-03 | Developmental deviations of association-network structural connectivity in youths with ADHD predict symptom and treatment outcomes — Nat Biomed Eng ([PMID 42675180](https://pubmed.ncbi.nlm.nih.gov/42675180/){target="_blank" rel="noopener"}) | biomarkers |
| 2026-08-03 | A script concordance test to implement 2024 HAS ADHD guidelines in primary care — Encephale ([PMID 42674891](https://pubmed.ncbi.nlm.nih.gov/42674891/){target="_blank" rel="noopener"}) | guidelines |
| 2026-08-02 | Obstetric Risk Associated With Stimulant Versus Nonstimulant Treatment During Pregnancy — J Clin Psychiatry ([PMID 42671280](https://pubmed.ncbi.nlm.nih.gov/42671280/){target="_blank" rel="noopener"}) | girls-women-and-hormonal-context |
| 2026-08-02 | Long-term outcomes of childhood ADHD stimulant use trajectories — Eur Neuropsychopharmacol ([PMID 42664720](https://pubmed.ncbi.nlm.nih.gov/42664720/){target="_blank" rel="noopener"}) | long-term-outcomes-and-quality-of-life |
| 2026-08-02 | Long-term effects of cognitive behavioural therapy on the quality of life in adult ADHD — PLoS One ([PMID 42664236](https://pubmed.ncbi.nlm.nih.gov/42664236/){target="_blank" rel="noopener"}) | adult-adhd, psychosocial-and-digital-treatment |
| 2026-08-02 | Bridging gaps in ADHD care globally: lessons from the NHS England independent taskforce report — Br J Psychiatry ([PMID 42661151](https://pubmed.ncbi.nlm.nih.gov/42661151/){target="_blank" rel="noopener"}) | guidelines |
| 2026-08-02 | Prescription Use of Paracetamol During Pregnancy and Risk of Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder in Early Childhood — J Am Acad Child Adolesc Psychiatry ([PMID 42660286](https://pubmed.ncbi.nlm.nih.gov/42660286/){target="_blank" rel="noopener"}) | girls-women-and-hormonal-context |
| 2026-08-02 | Verbal fluency in individuals with attention deficit-hyperactivity disorder (ADHD): A meta-analysis — Acta Psychol (Amst) ([PMID 42659788](https://pubmed.ncbi.nlm.nih.gov/42659788/){target="_blank" rel="noopener"}) | comorbidity-and-differential-diagnosis |
| 2026-08-02 | Centanafadine (Simtriyo®): a first-in-class triple reuptake inhibitor approved for attention-deficit/hyperactivity disorder (ADHD) — Med Chem Res ([PMID 42640319](https://pubmed.ncbi.nlm.nih.gov/42640319/){target="_blank" rel="noopener"}) | guidelines, pharmacologic-treatment, red-flags-and-safety-concerns |
| 2026-08-01 | Time Trends in Maternal Attention-Deficit/Hyperactivity Disorder and Medication Use in Pregnancy — J Clin Psychiatry ([PMID 42671284](https://pubmed.ncbi.nlm.nih.gov/42671284/){target="_blank" rel="noopener"}) | girls-women-and-hormonal-context |
| 2026-07-01 | Consensus Statement on Digital Health and Attention-Deficit/Hyperactivity Disorder by the European Network for ADHD (EUNETHYDIS): Modified Delphi Study — J Med Internet Res ([PMID 42462051](https://pubmed.ncbi.nlm.nih.gov/42462051/){target="_blank" rel="noopener"}) | overview |
| 2026-07-01 | Real-world clinical validation of brainstem-based ocular biomarkers for ADHD classification in children and adults — Sci Rep ([PMID 42448769](https://pubmed.ncbi.nlm.nih.gov/42448769/){target="_blank" rel="noopener"}) | biomarkers |
| 2026-06-09 | Mortality in people with attention-deficit/hyperactivity disorder (ADHD): Examining how risk is embodied in a pooling of two prospective cohort studies — medRxiv ([PMID 42326778](https://pubmed.ncbi.nlm.nih.gov/42326778/){target="_blank" rel="noopener"}) | long-term-outcomes-and-quality-of-life |
| 2026-06-05 | Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Psychopharmacol Bull ([PMID 42267239](https://pubmed.ncbi.nlm.nih.gov/42267239/){target="_blank" rel="noopener"}) | pharmacologic-treatment |
| 2026-06-02 | Diagnosis of ADHD in children from EEG signals using amplitude modulation features — Comput Biol Med ([PMID 42322747](https://pubmed.ncbi.nlm.nih.gov/42322747/){target="_blank" rel="noopener"}) | biomarkers |
| 2026-06-01 | Effectiveness of an attention enhancement task on executive function in children with attention deficit-hyperactivity disorder: A systematic review and meta-analysis — J Child Adolesc Ment Health ([PMID 42287019](https://pubmed.ncbi.nlm.nih.gov/42287019/){target="_blank" rel="noopener"}) | childhood-and-adolescent-adhd |
| 2026-06-01 | Menstrual health and Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms: A scoping review — Womens Health (Lond) ([PMID 42274016](https://pubmed.ncbi.nlm.nih.gov/42274016/){target="_blank" rel="noopener"}) | girls-women-and-hormonal-context |
| 2026-06-01 | Pharmacological interventions for ADHD: a systematic review and dose-effect network meta-analysis — Lancet Psychiatry ([PMID 42134365](https://pubmed.ncbi.nlm.nih.gov/42134365/){target="_blank" rel="noopener"}) | adult-adhd, clinical-trials-landscape, pharmacologic-treatment |
| 2026-05-03 | A Systematic Review of Lived Experiences of Receiving a Diagnosis of ADHD in Adulthood — J Atten Disord ([PMID 42216788](https://pubmed.ncbi.nlm.nih.gov/42216788/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy |
| 2026-05-02 | The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD(✰) — Eur Neuropsychopharmacol ([PMID 42160906](https://pubmed.ncbi.nlm.nih.gov/42160906/){target="_blank" rel="noopener"}) | guidelines |
| 2026-05-01 | Effects of a novel individualized digital cognitive training on ADHD characteristics, quality of life, and cognitive functioning in adults with ADHD: A randomized controlled trial — J Psychiatr Res ([PMID 42142506](https://pubmed.ncbi.nlm.nih.gov/42142506/){target="_blank" rel="noopener"}) | clinical-trials-landscape |
| 2026-04-03 | A qualitative investigation of the lived experiences of adults with anxiety and related disorders and ADHD: Interconnectedness of symptoms and implications for improving care — Br J Clin Psychol ([PMID 41930671](https://pubmed.ncbi.nlm.nih.gov/41930671/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy |
| 2026-04-02 | Early attention deficit hyperactivity disorder prediction from longitudinal electronic health records — Nat Ment Health ([PMID 42828415](https://pubmed.ncbi.nlm.nih.gov/42828415/){target="_blank" rel="noopener"}) | biomarkers |
| 2026-04-02 | Stigma in adults with ADHD: a systematic review of types, experiences, and potential implications for quality of life — Front Psychiatry ([PMID 42137527](https://pubmed.ncbi.nlm.nih.gov/42137527/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy |
| 2026-04-02 | Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause — Drugs Aging ([PMID 42018215](https://pubmed.ncbi.nlm.nih.gov/42018215/){target="_blank" rel="noopener"}) | girls-women-and-hormonal-context |
| 2026-03-09 | Four decades of ADHD: a systematic AI-assisted analysis of conceptual shifts across six DSM editions — Front Psychiatry ([PMID 41877875](https://pubmed.ncbi.nlm.nih.gov/41877875/){target="_blank" rel="noopener"}) | history-nosology-and-presentations |
| 2026-03-02 | 3D ADHD-Net and DeepTrace: Decoding ADHD from EEG with neurophysiological insights — Appl Neuropsychol Child ([PMID 41883314](https://pubmed.ncbi.nlm.nih.gov/41883314/){target="_blank" rel="noopener"}) | biomarkers |
| 2026-03-01 | Experience of the diagnostic journey for ADHD in adulthood: A quantitative and qualitative study — Encephale ([PMID 41833504](https://pubmed.ncbi.nlm.nih.gov/41833504/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy |
| 2026-03-01 | Effectiveness of attexis, a digital intervention based on cognitive behavioral therapy for adults with ADHD: a randomized controlled trial — Psychol Med ([PMID 41810578](https://pubmed.ncbi.nlm.nih.gov/41810578/){target="_blank" rel="noopener"}) | clinical-trials-landscape |
| 2026-02-02 | Energy deficit hyperactivity disorder (EDHD): A neurobiological energy dysregulation model for ADHD — Neurosci Biobehav Rev ([PMID 41765196](https://pubmed.ncbi.nlm.nih.gov/41765196/){target="_blank" rel="noopener"}) | history-nosology-and-presentations |
| 2026-02-02 | Validity of screening tools and risk factors for Co-occurring ADHD in children with epilepsy: a systematic review and meta-analysis — Epilepsy Behav ([PMID 41740565](https://pubmed.ncbi.nlm.nih.gov/41740565/){target="_blank" rel="noopener"}) | history-nosology-and-presentations |
| 2026-01-02 | Mapping the Mind: A Network Meta-Analysis of Mindfulness and Traditional and Digital Interventions for Cognitive and Behavioral Enhancement in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) — Cureus ([PMID 41769550](https://pubmed.ncbi.nlm.nih.gov/41769550/){target="_blank" rel="noopener"}) | psychosocial-and-digital-treatment |
| 2026-01-02 | A multi-cohort assessment of the polygenic prediction in ADHD treatment response — Psychiatry Res ([PMID 41655471](https://pubmed.ncbi.nlm.nih.gov/41655471/){target="_blank" rel="noopener"}) | diagnosis-and-assessment |
| 2026-01-02 | A systematic review of transcranial direct current stimulation (tDCS) for adults with attention deficit/hyperactivity disorder (ADHD) — J Psychiatr Res ([PMID 41610600](https://pubmed.ncbi.nlm.nih.gov/41610600/){target="_blank" rel="noopener"}) | clinical-trials-landscape |
| 2026-01-02 | Disparities in Adult ADHD Care Delivery Among U.S. Telepsychology Providers — J Atten Disord ([PMID 41571598](https://pubmed.ncbi.nlm.nih.gov/41571598/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy |
| 2026-01-02 | The lived experience of rejection sensitivity in ADHD - A qualitative exploration — PLoS One ([PMID 41564005](https://pubmed.ncbi.nlm.nih.gov/41564005/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy |
| 2026-01-01 | A meta-analysis of the intervention effect of cognitive behavioral therapy on adult ADHD — J Affect Disord ([PMID 41483880](https://pubmed.ncbi.nlm.nih.gov/41483880/){target="_blank" rel="noopener"}) | psychosocial-and-digital-treatment |
| 2025-12-08 | Integrative literature review - the impact of ADHD across women's lifespan — BMC Womens Health ([PMID 41361438](https://pubmed.ncbi.nlm.nih.gov/41361438/){target="_blank" rel="noopener"}) | girls-women-and-hormonal-context |
| 2025-12-06 | ADHD and the Risk of Benzodiazepine Misuse: A Systematic Review and Meta-Analysis — Subst Use Misuse ([PMID 41352760](https://pubmed.ncbi.nlm.nih.gov/41352760/){target="_blank" rel="noopener"}) | comorbidity-and-differential-diagnosis |
| 2025-12-04 | Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) — Cochrane Database Syst Rev ([PMID 41342306](https://pubmed.ncbi.nlm.nih.gov/41342306/){target="_blank" rel="noopener"}) | childhood-and-adolescent-adhd, red-flags-and-safety-concerns |
| 2025-12-02 | Menstrual Cycle-Related Hormonal Fluctuations in ADHD: Effect on Cognitive Functioning-A Narrative Review — J Clin Med ([PMID 41517370](https://pubmed.ncbi.nlm.nih.gov/41517370/){target="_blank" rel="noopener"}) | girls-women-and-hormonal-context |
| 2025-12-02 | Changes in ADHD Symptoms and Mood Across the Menstrual Cycle in Females Treated With Stimulants: A Pilot Study — J Atten Disord ([PMID 41451846](https://pubmed.ncbi.nlm.nih.gov/41451846/){target="_blank" rel="noopener"}) | girls-women-and-hormonal-context |
| 2025-12-01 | Efficacy and safety of transcranial alternating current stimulation in adults with attention deficit hyperactivity disorder: a double-blind randomized sham-controlled trial — Mol Psychiatry ([PMID 41420112](https://pubmed.ncbi.nlm.nih.gov/41420112/){target="_blank" rel="noopener"}) | clinical-trials-landscape |
Trials — what has moved¶
18 registered trials are cited by this condition's pages. Registry records were re-checked live when this page was generated, so status, enrolment and results-posting below reflect ClinicalTrials.gov as of that date.
| Registry activity | Trials |
|---|---|
| trial records updated in the last week | 0 |
| trial records updated in the last month | 1 |
| trial records updated in the last 2 months | 6 |
| trial records updated in the last 3 months | 7 |
| trial records updated in the last 6 months | 9 |
| trial records updated in the last year | 10 |
Recently updated registrations¶
Posted efficacy and safety results¶
Trials whose sponsors have posted results to the registry. Adverse-event figures are participant counts summed across all arms as reported — read them against enrolment, and follow the registry link for the arm-by-arm breakdown that determines whether a signal is real.
| Results posted | Trial | Phase | N | Primary outcome | Serious AE | Other AE | Deaths |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Treating Parents With ADHD and Their Young Children Via Telehealth: A | PHASE3 | 269 | Change in Child Impairment | 0 | 44 | 0 |
| 2020-07-24 | Software Treatment for Actively Reducing Severity of ADHD | NA | 348 | Test of Variables of Attention-Attention Performance Index (Change Fro | 0 | 15 | 0 |
12 of these trials are still recruiting or active — see the condition's clinical trials page for the full landscape.
Which pages rest on the newest evidence¶
🔥 marks a page citing three or more papers from the last year — the pages worth re-reading if you have been away.
| Page | Newest citation | In last year | Total citations |
|---|---|---|---|
| psychosocial-and-digital-treatment | 2026-10-09 | 6 | 36 |
| epidemiology-and-lifespan-course | 2026-10-08 | 4 | 36 |
| adult-adhd | 2026-10-07 | 6 | 36 |
| long-term-outcomes-and-quality-of-life | 2026-10-07 | 4 | 35 |
| clinical-trials-landscape | 2026-10-04 | 7 | 35 |
| girls-women-and-hormonal-context | 2026-10-01 | 11 | 37 |
| pharmacologic-treatment | 2026-09-02 | 9 | 41 |
| red-flags-and-safety-concerns | 2026-09-01 | 3 | 35 |
| biomarkers | 2026-08-03 | 6 | 35 |
| guidelines | 2026-08-03 | 4 | 36 |
| comorbidity-and-differential-diagnosis | 2026-08-02 | 3 | 32 |
| overview | 2026-07-01 | 1 | 32 |
| childhood-and-adolescent-adhd | 2026-06-01 | 3 | 32 |
| patient-experience-and-advocacy | 2026-05-03 | 8 | 32 |
| history-nosology-and-presentations | 2026-03-09 | 3 | 32 |
| diagnosis-and-assessment | 2026-01-02 | 1 | 32 |
| genetics-and-neurobiology | 2025-08-01 | 0 | 32 |
| cognitive-and-functional-phenotypes | 2025-02-02 | 0 | 32 |
Recency is not quality: an old paper may be the definitive one, and a new paper may not replicate. Use this to find movement, not to rank evidence. See open questions for what remains unresolved, and the curation log for when these pages were last revised.